John C. Martin
E551391
John C. Martin was an American pharmaceutical executive and scientist best known for leading Gilead Sciences’ rise into a major biopharmaceutical company, particularly in antiviral and HIV/hepatitis C treatments.
All labels observed (1)
| Label | Occurrences |
|---|---|
| John C. Martin canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4050913 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: John C. Martin Context triple: [Gilead Sciences, foundedBy, John C. Martin]
-
A.
James L. Massey
James L. Massey was an American information theorist and cryptographer known for his fundamental contributions to coding theory, stream ciphers, and the development of the Berlekamp–Massey algorithm.
-
B.
Robert N. Fitch
Robert N. Fitch was a composer best known for writing the University of California fight song "Fight for California."
-
C.
Robert M. Stevens
Robert M. Stevens is a cinematographer known for his work on feature films, including the romantic comedy "40 Days and 40 Nights."
-
D.
Henry F. Korth
Henry F. Korth is a prominent computer scientist known for his influential work in database systems and co-authorship of a leading textbook in the field.
-
E.
Fred M. Wilcox
Fred M. Wilcox was an American film director best known for the science fiction classic "Forbidden Planet" and the family film "Lassie Come Home."
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: John C. Martin Target entity description: John C. Martin was an American pharmaceutical executive and scientist best known for leading Gilead Sciences’ rise into a major biopharmaceutical company, particularly in antiviral and HIV/hepatitis C treatments.
-
A.
James L. Massey
James L. Massey was an American information theorist and cryptographer known for his fundamental contributions to coding theory, stream ciphers, and the development of the Berlekamp–Massey algorithm.
-
B.
Robert N. Fitch
Robert N. Fitch was a composer best known for writing the University of California fight song "Fight for California."
-
C.
Robert M. Stevens
Robert M. Stevens is a cinematographer known for his work on feature films, including the romantic comedy "40 Days and 40 Nights."
-
D.
Henry F. Korth
Henry F. Korth is a prominent computer scientist known for his influential work in database systems and co-authorship of a leading textbook in the field.
-
E.
Fred M. Wilcox
Fred M. Wilcox was an American film director best known for the science fiction classic "Forbidden Planet" and the family film "Lassie Come Home."
- F. None of above. chosen
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
human
ⓘ
pharmaceutical executive ⓘ scientist ⓘ |
| academicDegree |
MBA
ⓘ
PhD in organic chemistry ⓘ bachelor’s degree in chemical engineering ⓘ |
| countryOfCitizenship | United States of America ⓘ |
| educatedAt |
Purdue University
ⓘ
Stanford University ⓘ University of Chicago ⓘ |
| employer |
Gilead Sciences
ⓘ
linked to:
Gilead Sciences (board member)
|
| fieldOfWork |
HIV treatment
ⓘ
antiviral drugs ⓘ hepatitis C treatment ⓘ pharmaceutical industry ⓘ |
| gender | male ⓘ |
| hasExpertise |
business management
ⓘ
drug development ⓘ organic chemistry ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
commercial success of HIV medications at Gilead Sciences
ⓘ
commercial success of hepatitis C medications at Gilead Sciences ⓘ expanding Gilead Sciences into a major biopharmaceutical company ⓘ strategic focus on antiviral therapeutics ⓘ |
| languageOfWorkOrName | English ⓘ |
| memberOf |
Gilead Sciences board of directors
ⓘ
linked to:
Gilead Sciences (board member)
|
| notableFor |
development and commercialization of antiviral therapies
ⓘ
leadership of Gilead Sciences ⓘ transforming Gilead Sciences into a leading antiviral company ⓘ |
| notableWork |
leadership in development of HIV antiviral regimens at Gilead Sciences
ⓘ
leadership in development of hepatitis C antiviral regimens at Gilead Sciences ⓘ |
| occupation |
pharmaceutical executive
ⓘ
scientist ⓘ |
| positionHeld |
Chairman of Gilead Sciences
ⓘ
Chief Executive Officer of Gilead Sciences ⓘ President of Gilead Sciences ⓘ |
| residence |
California
ⓘ
linked to:
California, United States
|
| workLocation |
California
ⓘ
linked to:
California, United States
Foster City, California ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: John C. Martin Description of subject: John C. Martin was an American pharmaceutical executive and scientist best known for leading Gilead Sciences’ rise into a major biopharmaceutical company, particularly in antiviral and HIV/hepatitis C treatments.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject linked to:
Gilead Sciences (board member)